- Home
- XRX vs EVMN Comparison
XRX vs EVMN Comparison
Compare XRX & EVMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XRX | EVMN |
|---|---|---|
| Founded | 1906 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer peripheral equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 416.3M | 474.7M |
| IPO Year | 2019 | 2025 |
Fundamental Metrics
Financial Performance| Metric | XRX | EVMN |
|---|---|---|
| Price | $3.39 | $9.63 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 10 |
| Target Price | $2.50 | ★ $43.88 |
| AVG Volume (30 Days) | ★ 2.3M | 590.1K |
| Earning Date | 04-30-2026 | 06-11-2026 |
| Dividend Yield | ★ 6.31% | N/A |
| EPS Growth | 23.26 | ★ 75.23 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $117,000,000.00 | $13,000,000.00 |
| Revenue This Year | $8.96 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 85.71 |
| 52 Week Low | $1.19 | $9.30 |
| 52 Week High | $4.27 | $33.20 |
Technical Indicators
Market Signals| Indicator | XRX | EVMN |
|---|---|---|
| Relative Strength Index (RSI) | 56.26 | 30.42 |
| Support Level | $2.50 | N/A |
| Resistance Level | $3.69 | $13.35 |
| Average True Range (ATR) | 0.20 | 0.67 |
| MACD | 0.03 | -0.28 |
| Stochastic Oscillator | 59.39 | 8.80 |
Price Performance
Historical ComparisonAbout XRX Xerox Holdings Corporation
Xerox Holdings Corp is a workplace technology company, building and integrating services-led, software-enabled, workplace solutions for enterprises large and small. It provide advance document technology, services, software, and integrated IT infrastructure solutions for a range of customers including small and mid-sized businesses, large enterprises, governments and graphic communications providers, and for partners who serve them. Xerox serves customers globally in North America, Europe, Latin America, Brazil, Asia Pacific (APAC), the Middle East, Africa, and India.
About EVMN Evommune Inc.
Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.